Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308492036> ?p ?o ?g. }
- W4308492036 endingPage "10" @default.
- W4308492036 startingPage "5" @default.
- W4308492036 abstract "This study aimed to elucidate a potential dose-dependent relation between coffee intake and atrial fibrillation (AF) incidence in a multi-ethnic setting. Previous studies were comprised mainly of White populations, and an exploration of dose dependency is limited. To address these gaps, we analyzed the Multi-Ethnic Study of Atherosclerosis data, a prospective cohort study. In the primary analysis, we crudely divided patients into 3 groups: nonconsumers, 1 to 3 cups/month, and ≥1 cup/week. For the secondary analysis, we stratified the cohort into 9 groups of gradual increments for coffee consumption. A multivariable cox proportional hazards regression model was adjusted for 6 potential confounders: age, gender, smoking, hypertension, diabetes mellitus, and alcohol. Subjects who drank ≥1 cup of coffee/week had a higher incidence of AF (adjusted hazard ratio 1.40, p = 0.015) than nonconsumers. Furthermore, in the secondary analysis, there was an overall trend, albeit not consistent, of increasing adjusted hazard ratio with progressively increasing doses of coffee in the following groups: 1 to 3 cups/month, 2 to 4 cups/week, 2 to 3 cups/day and ≥6 cups/day. Notably, AF incidence was highest (9.8%) for the group consuming the most coffee, that is, ≥6 cups/day (p = 0.02). Stratification by race/ethnicity suggested the results may be driven by White and Hispanic rather than Black or Chinese-American subgroups. In conclusion, the findings suggest an association between coffee consumption and incident AF in contrast to most previous studies. This study aimed to elucidate a potential dose-dependent relation between coffee intake and atrial fibrillation (AF) incidence in a multi-ethnic setting. Previous studies were comprised mainly of White populations, and an exploration of dose dependency is limited. To address these gaps, we analyzed the Multi-Ethnic Study of Atherosclerosis data, a prospective cohort study. In the primary analysis, we crudely divided patients into 3 groups: nonconsumers, 1 to 3 cups/month, and ≥1 cup/week. For the secondary analysis, we stratified the cohort into 9 groups of gradual increments for coffee consumption. A multivariable cox proportional hazards regression model was adjusted for 6 potential confounders: age, gender, smoking, hypertension, diabetes mellitus, and alcohol. Subjects who drank ≥1 cup of coffee/week had a higher incidence of AF (adjusted hazard ratio 1.40, p = 0.015) than nonconsumers. Furthermore, in the secondary analysis, there was an overall trend, albeit not consistent, of increasing adjusted hazard ratio with progressively increasing doses of coffee in the following groups: 1 to 3 cups/month, 2 to 4 cups/week, 2 to 3 cups/day and ≥6 cups/day. Notably, AF incidence was highest (9.8%) for the group consuming the most coffee, that is, ≥6 cups/day (p = 0.02). Stratification by race/ethnicity suggested the results may be driven by White and Hispanic rather than Black or Chinese-American subgroups. In conclusion, the findings suggest an association between coffee consumption and incident AF in contrast to most previous studies." @default.
- W4308492036 created "2022-11-12" @default.
- W4308492036 creator A5017726219 @default.
- W4308492036 creator A5021899274 @default.
- W4308492036 creator A5023850643 @default.
- W4308492036 creator A5024978059 @default.
- W4308492036 creator A5027865922 @default.
- W4308492036 creator A5043658621 @default.
- W4308492036 creator A5054563658 @default.
- W4308492036 creator A5061999743 @default.
- W4308492036 creator A5077592463 @default.
- W4308492036 creator A5079546501 @default.
- W4308492036 creator A5084410155 @default.
- W4308492036 creator A5086294602 @default.
- W4308492036 date "2023-01-01" @default.
- W4308492036 modified "2023-09-30" @default.
- W4308492036 title "Association Between Coffee Consumption and Incident Atrial Fibrillation (from the Multi-Ethnic Study of Atherosclerosis [MESA])" @default.
- W4308492036 cites W107772953 @default.
- W4308492036 cites W1539721984 @default.
- W4308492036 cites W2006899270 @default.
- W4308492036 cites W2017903258 @default.
- W4308492036 cites W2031203816 @default.
- W4308492036 cites W2039152180 @default.
- W4308492036 cites W2052706088 @default.
- W4308492036 cites W2071594712 @default.
- W4308492036 cites W2076410967 @default.
- W4308492036 cites W2077267408 @default.
- W4308492036 cites W2092713330 @default.
- W4308492036 cites W2098995865 @default.
- W4308492036 cites W2105863299 @default.
- W4308492036 cites W2131404482 @default.
- W4308492036 cites W2148523405 @default.
- W4308492036 cites W2150445954 @default.
- W4308492036 cites W2153858333 @default.
- W4308492036 cites W2156097706 @default.
- W4308492036 cites W2160464880 @default.
- W4308492036 cites W2164861810 @default.
- W4308492036 cites W2265004579 @default.
- W4308492036 cites W2531580185 @default.
- W4308492036 cites W2609226361 @default.
- W4308492036 cites W2794394113 @default.
- W4308492036 cites W2800155270 @default.
- W4308492036 cites W2978759688 @default.
- W4308492036 cites W3012171030 @default.
- W4308492036 cites W3103711573 @default.
- W4308492036 cites W3122226502 @default.
- W4308492036 doi "https://doi.org/10.1016/j.amjcard.2022.10.025" @default.
- W4308492036 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36334435" @default.
- W4308492036 hasPublicationYear "2023" @default.
- W4308492036 type Work @default.
- W4308492036 citedByCount "0" @default.
- W4308492036 crossrefType "journal-article" @default.
- W4308492036 hasAuthorship W4308492036A5017726219 @default.
- W4308492036 hasAuthorship W4308492036A5021899274 @default.
- W4308492036 hasAuthorship W4308492036A5023850643 @default.
- W4308492036 hasAuthorship W4308492036A5024978059 @default.
- W4308492036 hasAuthorship W4308492036A5027865922 @default.
- W4308492036 hasAuthorship W4308492036A5043658621 @default.
- W4308492036 hasAuthorship W4308492036A5054563658 @default.
- W4308492036 hasAuthorship W4308492036A5061999743 @default.
- W4308492036 hasAuthorship W4308492036A5077592463 @default.
- W4308492036 hasAuthorship W4308492036A5079546501 @default.
- W4308492036 hasAuthorship W4308492036A5084410155 @default.
- W4308492036 hasAuthorship W4308492036A5086294602 @default.
- W4308492036 hasConcept C120665830 @default.
- W4308492036 hasConcept C121332964 @default.
- W4308492036 hasConcept C126322002 @default.
- W4308492036 hasConcept C134018914 @default.
- W4308492036 hasConcept C144024400 @default.
- W4308492036 hasConcept C149923435 @default.
- W4308492036 hasConcept C151956035 @default.
- W4308492036 hasConcept C164705383 @default.
- W4308492036 hasConcept C188816634 @default.
- W4308492036 hasConcept C199360897 @default.
- W4308492036 hasConcept C201903717 @default.
- W4308492036 hasConcept C207103383 @default.
- W4308492036 hasConcept C2779161974 @default.
- W4308492036 hasConcept C2780940541 @default.
- W4308492036 hasConcept C41008148 @default.
- W4308492036 hasConcept C44249647 @default.
- W4308492036 hasConcept C50382708 @default.
- W4308492036 hasConcept C555293320 @default.
- W4308492036 hasConcept C61511704 @default.
- W4308492036 hasConcept C71924100 @default.
- W4308492036 hasConcept C72563966 @default.
- W4308492036 hasConcept C77350462 @default.
- W4308492036 hasConceptScore W4308492036C120665830 @default.
- W4308492036 hasConceptScore W4308492036C121332964 @default.
- W4308492036 hasConceptScore W4308492036C126322002 @default.
- W4308492036 hasConceptScore W4308492036C134018914 @default.
- W4308492036 hasConceptScore W4308492036C144024400 @default.
- W4308492036 hasConceptScore W4308492036C149923435 @default.
- W4308492036 hasConceptScore W4308492036C151956035 @default.
- W4308492036 hasConceptScore W4308492036C164705383 @default.
- W4308492036 hasConceptScore W4308492036C188816634 @default.
- W4308492036 hasConceptScore W4308492036C199360897 @default.
- W4308492036 hasConceptScore W4308492036C201903717 @default.
- W4308492036 hasConceptScore W4308492036C207103383 @default.